Floxacillin
ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: flucloxacillin, flucloxacillin sodium, fluocloxacilin, fluoxacillin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Floxacillin is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1962. DrugCentral lists 3 molecular targets, including AR, MMP9 and pbpA.
- Molecular targets: AR, MMP9 and pbpA (3 listed in DrugCentral).
- ATC code: J01CF05 (Beta-lactamase resistant penicillins).
- Molecular formula: C19H17ClFN3O5S; molecular weight 453.87 g/mol.
Mechanism & targets
Molecular targets (3)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Androgen receptor | AR | unknown | IC50 6.25 |
| Matrix metalloproteinase-9 | MMP9 | unknown | IC50 4.19 |
| Penicillin-binding protein 1A | pbpA | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1962-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01CF05 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › BETA-LACTAM ANTIBACTERIALS, PENICILLINS › Beta-lactamase resistant penicillins |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Metabolic acidosis | 820.0 |
| Drug interaction | 537.3 |
| Pyroglutamic acidosis | 517.7 |
| Pyroglutamate increased | 247.9 |
| Cellulitis | 176.8 |
| Acute kidney injury | 152.3 |
| Drug level decreased | 140.9 |
| Immunosuppressant drug level decreased | 103.7 |
| Acidosis | 98.3 |
| Lip swelling | 94.8 |
| Drug reaction with eosinophilia and systemic symptoms | 94.0 |
| Stevens-Johnson syndrome | 84.5 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Floxacillin is on its molecule page.
| Molecular formula | C19H17ClFN3O5S |
|---|---|
| Molecular weight | 453.87 g/mol |
| CAS number | 5250-39-5 |
| InChIKey | UIOFUWFRIANQPC-JKIFEVAISA-N |
| PubChem CID | 21319 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Floxacillin work?
Its molecular targets in DrugCentral include AR, MMP9 and pbpA.
When was Floxacillin first approved?
Floxacillin was first approved by the YEAR INTRODUCED in 1962.
What is the chemical formula of Floxacillin?
Floxacillin has the molecular formula C19H17ClFN3O5S and a molecular weight of 453.87 g/mol.
Browse: all drugs starting with F · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1183 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL222645 — compound record and bioactivity
- PubChem CID 21319 — chemical identifiers
- DrugBank DB00301 — drug record
- FDA UNII 43B2M34G2V — substance identity
- UniProt P10275 (AR) — target protein
- UniProt P14780 (MMP9) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.